Fighting the superbug: new hope for patients with untreatable infections
NCT ID NCT07431307
Summary
This study is testing a new antibiotic combination called BV100 for patients with severe hospital-acquired infections caused by a dangerous, drug-resistant bacteria. It will compare BV100 combined with other antibiotics against the current best available treatments. The goal is to see if the new combination is safer and more effective at controlling these life-threatening infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD STREAM INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.